Overview
Xiaomin Cheng practices practicing medicine in China.
Their clinical expertise encompasses Togaviridae Disease, COVID-19, and Severe Acute Respiratory Syndrome (SARS).
They are actively involved in clinical research, co-authoring 11 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Xiaomin Cheng
Is Xiaomin Cheng a top-rated expert for Togaviridae Disease?
MediFind is an objective health platform that identifies experts based on real-world data. Xiaomin Cheng is classified as an Experienced expert for Togaviridae Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Xiaomin Cheng participate in research or clinical trials?
Yes. Xiaomin Cheng has published 11 articles and abstracts on conditions like Togaviridae Disease. You can view a list of Xiaomin Cheng's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- COVID-19Cheng isExperienced. Learn about COVID-19.
- Severe Acute Respiratory Syndrome (SARS)
- Togaviridae DiseaseCheng isExperienced. Learn about Togaviridae Disease.